Stefania Mariani1, Daniela Fiore2, Agnese Persichetti2, Sabrina Basciani2, Carla Lubrano2, Eleonora Poggiogalle2, Alfredo Genco3, Lorenzo Maria Donini2, Lucio Gnessi2. 1. Department of Experimental Medicine, Section of Medical Physiopathology and Endocrinology, Sapienza University of Rome, 00161, Rome, Italy. stefaniamariani@yahoo.com. 2. Department of Experimental Medicine, Section of Medical Physiopathology and Endocrinology, Sapienza University of Rome, 00161, Rome, Italy. 3. Department of Surgical Sciences, Surgical Endoscopy Unit, Sapienza University of Rome, Rome, Italy.
Abstract
BACKGROUND: Sirtuins (SIRTs), ubiquitous deacetylases, are main regulators of energy homeostasis and metabolism. SIRT1 has a positive impact on obesity, diabetes mellitus, liver steatosis, and other metabolic disorders. Lean subjects have higher expression of SIRT1 in the adipose tissue compared to obese. However, it is not known whether weight loss associates with changes in blood SIRT1. We evaluated the effect of weight loss on circulating SIRT1, metabolic parameters, and body composition. METHODS: Thirty-two obese subjects were studied before and 6 months after BioEnterics® Intragastric Balloon (BIB®) [22 patients, BMI 41.82 ± 6.28 kg/m(2)] or hypocaloric diet [10 patients, BMI 38.95 ± 6.90 kg/m(2)]. Plasma SIRT1, body composition, measures of metabolic syndrome (waist circumference, fasting plasma glucose, blood pressure, HDL cholesterol, triglycerides), and inflammation markers (ESR, CRP, fibrinogen) were recorded. RESULTS: SIRT1 levels showed a significant increase, together with a significant reduction of BMI, excess body weight, and total fat mass either after BIB or diet intervention. The percent excess body weight loss was 33.73 ± 19.06 and 22.08 ± 11.62 % after BIB and diet, respectively, a trend toward a metabolic and inflammatory amelioration was observed with both treatments. Negative correlation between SIRT1 and % fat mass (BIB, ρ = -0.537, p = 0.017; diet, ρ = -0.638, p = 0.047) was also seen. CONCLUSIONS: The reduction of fat mass associates with increased plasma SIRT1 indicating that, besides tissue levels, circulating SIRT1 is stimulated by a negative caloric balance. The rise of plasma SIRT1 may represent a parameter associating with fat loss rather than weight lowering regardless of the weight reduction system method used.
BACKGROUND: Sirtuins (SIRTs), ubiquitous deacetylases, are main regulators of energy homeostasis and metabolism. SIRT1 has a positive impact on obesity, diabetes mellitus, liver steatosis, and other metabolic disorders. Lean subjects have higher expression of SIRT1 in the adipose tissue compared to obese. However, it is not known whether weight loss associates with changes in blood SIRT1. We evaluated the effect of weight loss on circulating SIRT1, metabolic parameters, and body composition. METHODS: Thirty-two obese subjects were studied before and 6 months after BioEnterics® Intragastric Balloon (BIB®) [22 patients, BMI 41.82 ± 6.28 kg/m(2)] or hypocaloric diet [10 patients, BMI 38.95 ± 6.90 kg/m(2)]. Plasma SIRT1, body composition, measures of metabolic syndrome (waist circumference, fasting plasma glucose, blood pressure, HDL cholesterol, triglycerides), and inflammation markers (ESR, CRP, fibrinogen) were recorded. RESULTS:SIRT1 levels showed a significant increase, together with a significant reduction of BMI, excess body weight, and total fat mass either after BIB or diet intervention. The percent excess body weight loss was 33.73 ± 19.06 and 22.08 ± 11.62 % after BIB and diet, respectively, a trend toward a metabolic and inflammatory amelioration was observed with both treatments. Negative correlation between SIRT1 and % fat mass (BIB, ρ = -0.537, p = 0.017; diet, ρ = -0.638, p = 0.047) was also seen. CONCLUSIONS: The reduction of fat mass associates with increased plasma SIRT1 indicating that, besides tissue levels, circulating SIRT1 is stimulated by a negative caloric balance. The rise of plasma SIRT1 may represent a parameter associating with fat loss rather than weight lowering regardless of the weight reduction system method used.
Entities:
Keywords:
BIB; Fat mass; Obesity; SIRT1; Weight loss
Authors: Arun Baksi; Oleg Kraydashenko; Alsu Zalevkaya; Roman Stets; Peter Elliott; Jonathan Haddad; Ethan Hoffmann; George P Vlasuk; Eric W Jacobson Journal: Br J Clin Pharmacol Date: 2014-07 Impact factor: 4.335
Authors: Fateh Bazerbachi; Eric J Vargas; Monika Rizk; Daniel B Maselli; Taofic Mounajjed; Sudhakar K Venkatesh; Kymberly D Watt; John D Port; Rita Basu; Andres Acosta; Ibrahim Hanouneh; Naveen Gara; Meera Shah; Manpreet Mundi; Matthew Clark; Karen Grothe; Andrew C Storm; Michael J Levy; Barham K Abu Dayyeh Journal: Clin Gastroenterol Hepatol Date: 2020-04-30 Impact factor: 11.382
Authors: Stefania Mariani; Maria R di Giorgio; Paolo Martini; Agnese Persichetti; Giuseppe Barbaro; Sabrina Basciani; Savina Contini; Eleonora Poggiogalle; Antonio Sarnicola; Alfredo Genco; Carla Lubrano; Aldo Rosano; Lorenzo M Donini; Andrea Lenzi; Lucio Gnessi Journal: Front Endocrinol (Lausanne) Date: 2018-08-07 Impact factor: 5.555
Authors: Paula Rodriguez-Miguelez; Jacob Looney; Jeffrey Thomas; Gregory Harshfield; Jennifer S Pollock; Ryan A Harris Journal: Am J Physiol Heart Circ Physiol Date: 2020-04-24 Impact factor: 4.733
Authors: Alessandra Roggerio; Célia M Cassaro Strunz; Ana Paula Pacanaro; Dalila Pinheiro Leal; Julio Y Takada; Solange D Avakian; Antonio de Padua Mansur Journal: Nutrients Date: 2018-07-21 Impact factor: 5.717